COGNILYF TABLETS

Indications

• Acute ischemic stroke
• Traumatic brain injury
• Neurodegenerative disorders
• Cognitive impairment

Dosage

Children: Refer to specific clinical guidelines or consult a healthcare professional for dosing information.

Adults: Refer to specific clinical guidelines or consult a healthcare professional for dosing information.

Mechanism of action

Cerebroprotein is believed to exert its effects by modulating neurotrophic factors and enhancing synaptic plasticity. It may promote neuronal survival through its influence on cell signaling pathways that regulate apoptosis and cellular repair mechanisms.

Pharmacodynamics

Cerebroprotein demonstrates neuroprotective properties, promoting neuronal health and function. It may enhance cognitive functions and improve memory through its actions on neurotransmitter systems, particularly in conditions associated with neuronal damage.

Pharmacokinetics

The pharmacokinetics of cerebroprotein are not thoroughly characterized in the literature, but it is generally administered parenterally. Its distribution, metabolism, and elimination have not been well-defined due to the complexity of its biological origin.

Pregnancy

Cerebroprotein should be used during pregnancy only if the potential benefit justifies the potential risk to the fetus. Consult health care providers for guidance.

Breast-feeding

There is limited information on the excretion of cerebroprotein in human breast milk. Caution is advised when administering to nursing mothers.

Storage

Store at room temperature, away from light and moisture. Keep out of reach of children.

Indications

• Nutritional support in malnourished patients
• Post-operative recovery
• Management of malabsorption syndromes
• Support in conditions requiring enhanced protein intake

Dosage

Children: Refer to the BNF for Children for dosing recommendations.

Adults: Refer to specific formulations and BNF guidelines for appropriate dosing.

Mechanism of action

Hydrolysates increase the availability of amino acids and peptides for absorption in the intestines. The smaller size of these molecules compared to whole proteins facilitates their transport across the intestinal wall, allowing for quicker and more effective utilization by the body. This mechanism is particularly beneficial in patients with compromised digestive capabilities.

Pharmacodynamics

The pharmacodynamic effects of hydrolysates involve the supply of essential and non-essential amino acids, which are crucial for various metabolic processes, including protein synthesis, neurotransmitter production, and immune function. The rapid absorption of these peptides can lead to quicker recovery times in malnourished individuals or those undergoing surgical recovery.

Pharmacokinetics

Hydrolysates are rapidly absorbed in the gastrointestinal tract, with peak plasma concentrations occurring shortly after ingestion. The bioavailability of amino acids from hydrolysates is generally higher than that of intact proteins due to their smaller molecular size. The metabolism of amino acids occurs primarily in the liver, where they can be utilized for energy production or incorporated into new proteins. The elimination of amino acids happens through renal pathways, with excess being excreted in urine.

Pregnancy

Safety during pregnancy has not been established. Use only if the potential benefit justifies the potential risk to the fetus.

Breast-feeding

It is not known if hydrolysate is excreted in human milk. Caution should be exercised when administering to nursing mothers.

Storage

Store in a cool, dry place, away from light. Keep out of reach of children.